85 related articles for article (PubMed ID: 22957849)
1. Generation of new cytotoxic human ribonuclease variants directed to the nucleus.
Vert A; Castro J; Ruiz-Martínez S; Tubert P; Escribano D; Ribó M; Vilanova M; Benito A
Mol Pharm; 2012 Oct; 9(10):2894-902. PubMed ID: 22957849
[TBL] [Abstract][Full Text] [Related]
2. A nuclear localization sequence endows human pancreatic ribonuclease with cytotoxic activity.
Bosch M; Benito A; Ribó M; Puig T; Beaumelle B; Vilanova M
Biochemistry; 2004 Mar; 43(8):2167-77. PubMed ID: 14979713
[TBL] [Abstract][Full Text] [Related]
3. The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity.
Tubert P; Rodríguez M; Ribó M; Benito A; Vilanova M
Invest New Drugs; 2011 Oct; 29(5):811-7. PubMed ID: 20352290
[TBL] [Abstract][Full Text] [Related]
4. A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.
Vert A; Castro J; Ribó M; Benito A; Vilanova M
Oncotarget; 2016 Apr; 7(14):18309-24. PubMed ID: 26918450
[TBL] [Abstract][Full Text] [Related]
5. Construction of Highly Stable Cytotoxic Nuclear-Directed Ribonucleases.
Roura Padrosa D; Castro J; Romero-Casañas A; Ribó M; Vilanova M; Benito A
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544927
[TBL] [Abstract][Full Text] [Related]
6. A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines.
Castro J; Ribó M; Puig T; Colomer R; Vilanova M; Benito A
Invest New Drugs; 2012 Jun; 30(3):880-8. PubMed ID: 21286781
[TBL] [Abstract][Full Text] [Related]
7. A cytotoxic ribonuclease variant with a discontinuous nuclear localization signal constituted by basic residues scattered over three areas of the molecule.
Rodríguez M; Benito A; Tubert P; Castro J; Ribó M; Beaumelle B; Vilanova M
J Mol Biol; 2006 Jul; 360(3):548-57. PubMed ID: 16780873
[TBL] [Abstract][Full Text] [Related]
8. A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.
Castro J; Ribó M; Navarro S; Nogués MV; Vilanova M; Benito A
BMC Cancer; 2011 Jan; 11():9. PubMed ID: 21223552
[TBL] [Abstract][Full Text] [Related]
9. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
[TBL] [Abstract][Full Text] [Related]
10. Increasing the potency of a cytotoxin with an arginine graft.
Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT
Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi's sarcoma-associated herpesvirus.
Muñoz-Fontela C; Rodríguez E; Nombela C; Arroyo J; Rivas C
Biochem J; 2003 Sep; 374(Pt 2):545-50. PubMed ID: 12767255
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
[TBL] [Abstract][Full Text] [Related]
13. Production of engineered human pancreatic ribonucleases, solving expression and purification problems, and enhancing thermostability.
Canals A; Ribó M; Benito A; Bosch M; Mombelli E; Vilanova M
Protein Expr Purif; 1999 Oct; 17(1):169-81. PubMed ID: 10497083
[TBL] [Abstract][Full Text] [Related]
14. Disruption of shape-complementarity markers to create cytotoxic variants of ribonuclease A.
Rutkoski TJ; Kurten EL; Mitchell JC; Raines RT
J Mol Biol; 2005 Nov; 354(1):41-54. PubMed ID: 16188273
[TBL] [Abstract][Full Text] [Related]
15. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.
Suzuki M; Saxena SK; Boix E; Prill RJ; Vasandani VM; Ladner JE; Sung C; Youle RJ
Nat Biotechnol; 1999 Mar; 17(3):265-70. PubMed ID: 10096294
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the novel human gene, nuclear apoptosis-inducing factor 1, induces apoptosis.
Lv B; Shi T; Wang X; Song Q; Zhang Y; Shen Y; Ma D; Lou Y
Int J Biochem Cell Biol; 2006; 38(4):671-83. PubMed ID: 16378748
[TBL] [Abstract][Full Text] [Related]
17. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
18. Toward an antitumor form of bovine pancreatic ribonuclease: the crystal structure of three noncovalent dimeric mutants.
Merlino A; Russo Krauss I; Perillo M; Mattia CA; Ercole C; Picone D; Vergara A; Sica F
Biopolymers; 2009 Dec; 91(12):1029-37. PubMed ID: 19280639
[TBL] [Abstract][Full Text] [Related]
19. Human mRNA cap methyltransferase: alternative nuclear localization signal motifs ensure nuclear localization required for viability.
Shafer B; Chu C; Shatkin AJ
Mol Cell Biol; 2005 Apr; 25(7):2644-9. PubMed ID: 15767670
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity engineered on human pancreatic ribonuclease and onconase.
Torrent G; Ribó M; Benito A; Vilanova M
Mol Pharm; 2009; 6(2):531-42. PubMed ID: 19718804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
